Segment Results (Schedule Of Reconciliations Of Consolidated Adjusted Income (Loss) Before Income Tax) (Details) (USD $)	3 Months Ended				9 Months Ended
	Sep. 30, 2014		Sep. 30, 2013		Sep. 30, 2014		Sep. 30, 2013		Mar. 31, 2013 Chadds Ford, Pennsylvania Properties [Member]
Segment Reporting Information [Line Items]
Total segment adjusted income from continuing operations before income tax:	$ 329,480,000		$ 302,533,000		$ 882,680,000		$ 873,735,000
Corporate unallocated costs	(97,326,000)		(81,975,000)		(246,763,000)		(238,641,000)
Upfront and milestone payments to partners	(13,448,000)		(3,092,000)		(34,953,000)		(11,064,000)
Asset impairment charges	0		(807,000)		0		(4,756,000)
Acquisition-related and integration items	(6,932,000)	[1]	(1,493,000)	[1]	(71,819,000)	[1]	(3,876,000)	[1]
Separation benefits and other cost reduction initiatives	(8,230,000)	[2]	(20,673,000)	[2]	(19,970,000)	[2]	(85,929,000)	[2]
Excise tax	1,000,000	[3]	0	[3]	(54,300,000)	[3]	0	[3]
Amortization of intangible assets	(70,806,000)		(44,987,000)		(194,273,000)		(143,326,000)
Inventory step-up	(17,364,000)		0		(40,089,000)		0
Non-cash interest expense related to the 1.75% Convertible Senior Subordinated Notes	(1,992,000)		(5,704,000)		(11,307,000)		(16,816,000)
Loss on extinguishment of debt	(2,027,000)		0		(31,712,000)		(11,312,000)
Watson litigation settlement income, net	0		14,628,000		0		50,400,000
Certain litigation-related charges, net	(483,926,000)	[4]	(44,600,000)	[4]	(1,157,885,000)	[4]	(193,969,000)	[4]
Charge related to the non-recoverability of certain non-trade receivables	0		0		(10,000,000)		0
Net gain on sale of certain early-stage drug discovery and development assets	150,000		0		4,000,000		0
Foreign currency impact related to the remeasurement of intercompany debt instruments	5,740,000		0		5,740,000		0
Charge for an additional year of the branded prescription drug fee in accordance with IRS regulations issued in the third quarter of 2014	(24,972,000)		0		(24,972,000)		0
Other, net	(161,000)		0		(161,000)		1,048,000
(LOSS) INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAX	(390,814,000)		113,830,000		(1,005,784,000)		215,494,000
Severance costs	1,500,000		5,600,000		10,500,000		46,800,000
Operating leases, future minimum payments due									$ 7,200,000

[1] Acquisition-related and integration-items include costs directly associated with the closing of certain acquisitions, changes in the fair value of contingent consideration and the costs of integration activities related to both current and prior period acquisitions.

[2] Separation benefits and other cost reduction initiatives include employee separation costs of $1.5 million and $10.5 million during the three and nine months ended September 30, 2014, respectively, compared to $5.6 million and $46.8 million for the three and nine months ended September 30, 2013, respectively. Additionally, amounts during the three and nine months ended September 30, 2014 include costs associated with the sale of our HealthTronics business and changes in estimates related to certain cost reduction initiative accruals. Additionally, the amount of separation benefits and other cost reduction initiatives during the three and nine months ended September 30, 2013 includes an expense recorded upon the cease use date of our Chadds Ford, Pennsylvania and Westbury, New York properties in the first quarter of 2013, representing the liability for our remaining obligations under the respective lease agreements of $7.2 million. These expenses were primarily recorded as Selling, general and administrative and Research and development expense in our Condensed Consolidated Statements of Operations.

[3] This amount represents charges related to the expense for the reimbursement of director's and certain employee's excise tax liabilities pursuant to Section 4985 of the Internal Revenue Code.

[4] These amounts include charges for Litigation-related and other contingencies, net, consisting primarily of mesh-related product liability charges, as well as mesh litigation-related defense costs for the three and nine months ended September 30, 2014 and 2013.